CTEPH Treatment and PAH Riociguat Intermediates CAS 256376-65-5

Basic Info

Model No.: 256376-65-5

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

We are rich experience Riociguat Intermediates 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile CAS 256376-65-5 supplier in China. We have been engaged in this industry for many year. Riociguat, also known as BAY 63-2521, is a novel drug that is a stimulator of soluble guanylate cyclase (sGC). Experiment shows that it can treat chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). We supply high purity Riociguat Intermediates CAS NO 256376-65-5 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile is white powder which known for its small molecular, micronized grade and on sterile level. We can offer best service and fast delivery

Thera. Category: Anti-Pulmonary Hypertension

Cas No.: 256376-65-5

Synonym: 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile;1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile

Molecular Formula: C14H9FN4

Molecular Weight: 252.2464632

Assay: ≥98.%

Appearance: White Crystalline solid

Storage: normal

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Usage: Riociguat 256376-65-5 (BAY 63-2521, trade name Adempas) is a novel drug (by Bayer) that is a stimulator of soluble guanylate cyclase (sGC). Clinical trials have looked at riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.